All Stories

DBS startup Newronika nets European approval for adaptive Parkinson's therapy

Newronika's AlphaDBS system continuously adjusts its output based on real-time brain signals, instead of the conventional fixed-stimulation doses.

Mar 27, 2025 - 23:12
 0
DBS startup Newronika nets European approval for adaptive Parkinson's therapy
Newronika's AlphaDBS system continuously adjusts its output based on real-time brain signals, instead of the conventional fixed-stimulation doses.
Read More

Tags:

Previous Article

Supira Medical raises $120M to develop catheter-based ventricular heart pump

Next Article

Ascletis slashes funding for former core programs in pivot to obesity

Related Posts

Carisma winds down operations, lays off 95% of remaining staff

Carisma winds down operations, lays off 95% of remainin...

Apr 1, 2025  0

Ono pays $280M upfront for Ionis' antisense oligonucleotide for rare blood cancer

Ono pays $280M upfront for Ionis' antisense oligonucleo...

Mar 12, 2025  0

Boston Scientific backs mitral valve developer 4C Medical in $175M round

Boston Scientific backs mitral valve developer 4C Medic...

Mar 7, 2025  0